• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Multilocus Blood-Based Assay Targeting Circulating Tumor DNA Methylation Enables Early Detection and Early Relapse Prediction of Colorectal Cancer.

作者信息

Cai Guoxiang, Cai Mingyan, Feng Zhiqiang, Liu Rui, Liang Li, Zhou Pinghong, Zhu Boqun, Mo Shaobo, Wang Hui, Lan Xiaoliang, Cai Sanjun, Xu Ye, Wang Renjie, Dai Weixin, Han Lingyu, Xiang Wenqiang, Wang Beili, Guo Wei, Zhang Lijing, Zhou Changjiang, Luo Binyang, Li Yingfei, Nie Yuqiang, Ma Chengcheng, Su Zhixi

机构信息

Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China.

出版信息

Gastroenterology. 2021 Dec;161(6):2053-2056.e2. doi: 10.1053/j.gastro.2021.08.054. Epub 2021 Sep 4.

DOI:10.1053/j.gastro.2021.08.054
PMID:34487783
Abstract
摘要

相似文献

1
A Multilocus Blood-Based Assay Targeting Circulating Tumor DNA Methylation Enables Early Detection and Early Relapse Prediction of Colorectal Cancer.一种针对循环肿瘤DNA甲基化的多位点血液检测方法可实现结直肠癌的早期检测和早期复发预测。
Gastroenterology. 2021 Dec;161(6):2053-2056.e2. doi: 10.1053/j.gastro.2021.08.054. Epub 2021 Sep 4.
2
Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study.基于血液游离循环肿瘤细胞 DNA 的甲基化特征在结直肠癌早期检测中的发现和验证：一项病例对照研究。
Clin Epigenetics. 2021 Feb 3;13(1):26. doi: 10.1186/s13148-020-00985-4.
3
Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.新型 DNA 甲基化生物标志物具有高灵敏度和特异性，可用于基于血液的结直肠癌检测——一项临床生物标志物发现和验证研究。
Clin Epigenetics. 2019 Nov 14;11(1):158. doi: 10.1186/s13148-019-0757-3.
4
Diagnostic Power of DNA Methylation Classifiers for Early Detection of Cancer.用于癌症早期检测的 DNA 甲基化分类器的诊断效能。
Trends Cancer. 2020 Feb;6(2):78-81. doi: 10.1016/j.trecan.2019.12.006. Epub 2020 Feb 3.
5
Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.通过多重 MethyLight 分析检测血清 DNA 中 HOXA9 和 HIC1 的异常甲基化，用于上皮性卵巢癌的早期检测。
Int J Cancer. 2020 Sep 15;147(6):1740-1752. doi: 10.1002/ijc.32984. Epub 2020 Mar 31.
6
A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.一种新方法，通过对汇集样本中的循环无细胞游离 DNA 进行全基因组范围内的表观遗传组学发现，以开发用于结直肠癌筛查的非侵入性甲基化生物标志物。
Clin Epigenetics. 2018 Apr 16;10:53. doi: 10.1186/s13148-018-0487-y. eCollection 2018.
7
Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.无细胞游离 DNA 作为结直肠癌的一种基于血液的诊断生物标志物：系统评价。
J Surg Res. 2019 Apr;236:184-197. doi: 10.1016/j.jss.2018.11.029. Epub 2018 Dec 21.
8
Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.联合检测血浆GATA5和SFRP2甲基化是结直肠癌和腺瘤有效的非侵入性生物标志物。
World J Gastroenterol. 2015 Mar 7;21(9):2629-37. doi: 10.3748/wjg.v21.i9.2629.
9
The role of cell-free DNA in predicting colorectal cancer prognosis.游离 DNA 在预测结直肠癌预后中的作用。
Expert Rev Gastroenterol Hepatol. 2018 Jan;12(1):39-48. doi: 10.1080/17474124.2017.1372191. Epub 2017 Sep 7.
10
Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA.转移性结直肠癌患者使用循环肿瘤 DNA 进行术后随访的意义。
World J Gastroenterol. 2019 Dec 28;25(48):6939-6948. doi: 10.3748/wjg.v25.i48.6939.

引用本文的文献

1
Global burden of cancer attributable to high BMI (1990-2031): a multidimensional analysis based on GBD and Mendelian randomization.1990 - 2031年归因于高体重指数的全球癌症负担：基于全球疾病负担研究（GBD）和孟德尔随机化的多维度分析
Front Nutr. 2025 Aug 5;12:1618799. doi: 10.3389/fnut.2025.1618799. eCollection 2025.
2
Development and clinical applications of liquid biopsy assays in cancer screening.液体活检检测在癌症筛查中的发展与临床应用
Transl Cancer Res. 2025 Jun 30;14(6):3846-3859. doi: 10.21037/tcr-2025-272. Epub 2025 Jun 13.
3
Genome-Wide Methylation Sequencing to Identify DNA Methylation Markers for Early-stage Hepatocellular Carcinoma in Liver and Blood.
全基因组甲基化测序以鉴定肝脏和血液中早期肝细胞癌的DNA甲基化标志物
J Exp Clin Cancer Res. 2025 May 15;44(1):144. doi: 10.1186/s13046-025-03412-9.
4
Recurrence Prediction by Multi-Omics in the Patient with Colorectal Peritoneal Metastases After Cytoreductive Surgery: A Prospective Biomarker Study.多组学对结直肠癌腹膜转移患者减瘤手术后复发的预测：一项前瞻性生物标志物研究
Cancer Manag Res. 2025 Apr 29;17:893-904. doi: 10.2147/CMAR.S519094. eCollection 2025.
5
The Method of Minimal Residual Disease Detection With Circulating Tumor DNA and Its Clinical Applications in Colorectal Cancer.循环肿瘤DNA检测微小残留病的方法及其在结直肠癌中的临床应用
Cancer Rep (Hoboken). 2025 Mar;8(3):e70167. doi: 10.1002/cnr2.70167.
6
Innovative approaches in colorectal cancer screening: advances in detection methods and the role of artificial intelligence.结直肠癌筛查的创新方法：检测方法的进展及人工智能的作用
Therap Adv Gastroenterol. 2025 Jan 31;18:17562848251314829. doi: 10.1177/17562848251314829. eCollection 2025.
7
Whole-genome sequencing of cell-free DNA reveals DNA of tumor origin in plasma from patients with colorectal adenomas.游离DNA的全基因组测序揭示了结直肠腺瘤患者血浆中肿瘤来源的DNA。
Mol Oncol. 2025 Apr;19(4):984-993. doi: 10.1002/1878-0261.13803. Epub 2025 Jan 20.
8
Utilization of molecular genetic approaches for colorectal cancer screening.分子遗传学方法在结直肠癌筛查中的应用。
World J Gastroenterol. 2024 Dec 14;30(46):4950-4957. doi: 10.3748/wjg.v30.i46.4950.
9
Colorectal cancer screening using a multi-locus blood-based assay targeting circulating tumor DNA methylation: a cross-sectional study in an average-risk population.基于多基因血液检测的循环肿瘤 DNA 甲基化检测在一般风险人群中进行结直肠癌筛查的横断面研究。
BMC Med. 2024 Nov 27;22(1):560. doi: 10.1186/s12916-024-03777-2.
10
Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoring.粪便和血液生物标志物在结直肠癌管理中的应用：筛查和疾病监测的最新进展。
Mol Cancer. 2024 Nov 19;23(1):259. doi: 10.1186/s12943-024-02174-w.